Study of childhood-onset hereditary spastic paraplegia
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study follows people with hereditary spastic paraplegia that started in childhood to better understand how the condition progresses over time. It may help doctors learn what to expect and how to plan care, using genetic information and family history.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your spastic paraplegia symptoms started before you turned 18
- You are currently under 30 years old
- You have genetic test results showing a known spastic paraplegia-related gene change
- You have (or have been told you have) a relative who also has a confirmed diagnosis, if the study requires it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a one-time gene therapy (BFB-101) for children with SPG47, a genetic condition that affects movement and brain function. The therapy aims to deliver a working copy of the AP4B1 gene to help slow or stop the disease's progression.
This study looks at genes (DNA) to understand an inherited condition that causes gradually worsening leg stiffness. It may help researchers learn what causes the condition and potentially guide future care.
This trial aims to build a research network and gather information from people with two genetic types of hereditary spastic paraplegia (SPG4 and SPG5A). It will help doctors better understand these conditions and improve care.
This study looks at people in families with a known SPG4 gene change (a SPAST mutation) to understand early, subtle signs and the beginning of symptoms. It may help researchers find better ways to detect SPG4 earlier, before full walking problems start.
This study looks at the causes and biology (“biomarkers”) of hereditary spastic paraplegias and related conditions. You may join as someone with the condition, a family member without symptoms, or a healthy person, to help researchers understand what’s happening in the nervous system.
This registry collects information from people with hereditary spastic paraplegia or spastic ataxia to help plan future treatments. It aims to better understand the condition and connect patients with potential therapies.
Hear when a new Hereditary Spastic Paraplegia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.